CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors
Clinical trial NCT00819806 · COMPLETED
Trial details
- NCT number
- NCT00819806
- Sponsor
- Hassane M. Zarour, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2012-05-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.